Company intelligence / Profile preview
Inex Pharmaceuticals Corporation
Vancouver, British Columbia, Canadabiospace.com ↗
- Ownership
- Private
- Development stage
- Phase 3
01
Overview
Inex Pharmaceuticals developed liposomal formulations of off-patent cancer drugs. The company spun out its biotechnology business into Tekmira Pharmaceuticals in 2007. Three former Inex products reached the market: Marqibo (liposomal vincristine), Alocrest (liposomal vinorelbine) and Brakiva (liposomal topotecan).
- Therapeutic areas
- Oncology
- Modalities
- Liposomal drug deliveryRNAi technology
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Hana Biosciences, Inc.Alnylam Pharmaceuticals, Inc.Aradigm CorporationEsperion Therapeutics, Inc. (division of Pfizer Inc.)Talon Pharmaceuticals
Beyond the preview
Go deeper on Inex Pharmaceuticals Corporation.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Inex Pharmaceuticals Corporation.